Clinical trial
Bipolar II Depression: Lithium, SSRI, or the Combination
NCT00276965 · Lindner Center of HOPE, Other · Completed
Key facts
| NCT number | NCT00276965 |
|---|---|
| Title | Bipolar II Depression: Lithium, SSRI, or the Combination |
| Official title | Comparing the Safety and Effectiveness of a Mood Stabilizing Medication, an Antidepressant Medication, and a Combination of Both Medications to Treat Symptoms of Bipolar Type II Depression |
| Lead sponsor | Lindner Center of HOPE, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH University of California, Los Angeles Stanford University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Depression |
| Intervention type | Drug |
| Interventions | Sertraline, Lithium carbonate |
| Enrollment | 139 |
| Start date | Sep 1, 2006 |
| Primary completion | Mar 1, 2012 |
| Completion | Jul 1, 2012 |
| First posted | Jan 13, 2006 |
| Last update posted | May 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: